Literature DB >> 12838500

The relationship of cigarette smoking to end-stage renal disease.

Donald E Wesson1.   

Abstract

Cigarette smoking (CS) has been associated with augmented progression of nephropathies responsible for the 4 major causes of end-stage renal disease (ESRD) in the United States. CS has well-described ways by which it causes tissue injury in other organ systems and the mechanisms by which it adversely affects nephropathy progression might be similar. Therefore, exploring the mechanisms for CS-induced nephropathy or progression thereof might yield important insights into the general mechanisms by which some or most nephropathies progress to ESRD. In addition, CS can be discontinued and so is a potentially correctable risk factor for ESRD, a syndrome whose incidence continues to increase. Therefore, the mechanism(s) by which CS induces nephropathy progression is an important area of investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12838500     DOI: 10.1016/s0270-9295(03)00037-8

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  8 in total

1.  Genetic variants in nicotinic acetylcholine receptor genes jointly contribute to kidney function in American Indians: the Strong Heart Family Study.

Authors:  Yun Zhu; Jingyun Yang; Shengxu Li; Shelley A Cole; Karin Haack; Jason G Umans; Nora Franceschini; Barbara V Howard; Elisa T Lee; Jinying Zhao
Journal:  J Hypertens       Date:  2014-05       Impact factor: 4.844

Review 2.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

3.  Ignoring the obvious missing piece of chronic kidney disease in HIV: cigarette smoking.

Authors:  María José Míguez-Burbano; Christina Wyatt; John E Lewis; Allan Rodríguez; Robert Duncan
Journal:  J Assoc Nurses AIDS Care       Date:  2009-10-12       Impact factor: 1.354

4.  The effect of alcohol use on IL-6 responses across different racial/ethnic groups.

Authors:  María José Míguez; Rhonda Rosenberg; Ximena Burbano-Levy; Talita Carmona; Robert Malow
Journal:  Future Virol       Date:  2012-02       Impact factor: 1.831

Review 5.  Hypoxia: The Force that Drives Chronic Kidney Disease.

Authors:  Qiangwei Fu; Sean P Colgan; Carl Simon Shelley
Journal:  Clin Med Res       Date:  2016-02-04

6.  Smoking has no impact on survival and it is not associated with ACE gene I/D polymorphism in hemodialysis patients.

Authors:  István Kiss; Zoltán Kiss; Lóránt Kerkovits; András Paksy; Csaba Ambrus
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017-01       Impact factor: 1.636

7.  End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study.

Authors:  Helena Bleken Østergaard; Jan Westerink; Marianne C Verhaar; Michiel L Bots; Folkert W Asselbergs; Gert J de Borst; L Jaap Kappelle; Frank L J Visseren; Joep van der Leeuw
Journal:  J Nephrol       Date:  2021-03-13       Impact factor: 3.902

8.  Survival Percentile and Predictors of Difference in Survival among Hemodialysis Patients and Their Additive Interaction Using Laplace Regression.

Authors:  Salman Khazaei; Mehdi Yaseri; Vida Sheikh; Maryam Nazemipour; Ebrahim Hazrati; Mohammad Ali Mansournia
Journal:  J Res Health Sci       Date:  2020-11-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.